Novel styryl-indoles as small molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): Synthesis and biological evaluation.

[1]  O. Mäkitie,et al.  High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis , 2012, Head & neck.

[2]  Glenville Jones,et al.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.

[3]  D. Feldman,et al.  Vitamin D metabolism and action in the prostate: Implications for health and disease , 2011, Molecular and Cellular Endocrinology.

[4]  Dean E Brenner,et al.  CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma , 2010, Clinical Cancer Research.

[5]  H. DeLuca,et al.  Screening of selective inhibitors of 1α,25-dihydroxyvitamin D3 24-hydroxylase using recombinant human enzyme expressed in Escherichia coli. , 2010, Biochemistry.

[6]  A. Brancale,et al.  Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones. , 2010, European journal of medicinal chemistry.

[7]  Wei-dong Yu,et al.  CYP24A1 inhibition enhances the antitumor activity of calcitriol. , 2010, Endocrinology.

[8]  S. Yee,et al.  Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides. , 2010, Bioorganic & medicinal chemistry.

[9]  P. Hershberger,et al.  The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis , 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  Eric F. Johnson,et al.  Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. , 2010, Journal of molecular biology.

[11]  E. Negri,et al.  Dietary vitamin D and cancers of the oral cavity and esophagus. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[13]  D. Peehl,et al.  Potentiation of the growth-inhibitory effects of vitamin D in prostate cancer by genistein. , 2007, Nutrition reviews.

[14]  Andrea Brancale,et al.  Homology model of 1α,25-dihydroxyvitamin D3 24-hydroxylase cytochrome P450 24A1 (CYP24A1): Active site architecture and ligand binding , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  D. Neuberg,et al.  Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Yee,et al.  Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[18]  M. P. Bosch,et al.  A new, practical and efficient sulfone-mediated synthesis of trifluoromethyl ketones from alkyl and alkenyl bromides , 2005 .

[19]  C. Bertozzi,et al.  Mechanistic investigation of the staudinger ligation. , 2005, Journal of the American Chemical Society.

[20]  H. Morris.  Vitamin D: a hormone for all seasons--how much is enough? , 2005, The Clinical biochemist. Reviews.

[21]  H. DeLuca.  Overview of general physiologic features and functions of vitamin D. , 2004, The American journal of clinical nutrition.

[22]  Johan Moan,et al.  Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) , 2004, Cancer Causes & Control.

[23]  Takaaki Masuda,et al.  Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  C. Mioskowski,et al.  Preparation of alcohols from sulfones and trialkylboranes , 2003 .

[25]  R. Serda,et al.  Expression, structure‐function, and molecular modeling of vitamin D P450s , 2003, Journal of cellular biochemistry.

[26]  P. Nussbaumer,et al.  Inhibitors of vitamin D hydroxylases: Structure–activity relationships , 2003, Journal of cellular biochemistry.

[27]  P. Labute,et al.  Flexible alignment of small molecules. , 2001, Journal of medicinal chemistry.

[28]  R. Bouillon,et al.  Enhancement of antiproliferative activity of 1α,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  Nicholas A. Cortese,et al.  Palladium-catalyzed vinylic substitution reactions with carboxylic acid derivatives , 1977 .

[30]  E. Negri,et al.  Vitamin D intake and breast cancer risk: a case-control study in Italy. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Xiaoan Ruan,et al.  Expression of VDR and CYP24A1 mRNA in human tumors , 2005, Cancer Chemotherapy and Pharmacology.

[32]  W. Bentz,et al.  STRUCTURE FUNCTION , 1999 .